Cordis Hit With $22M Verdict In Stent Patent Case
A federal jury has found that Johnson & Johnson unit Cordis Corp. infringed a patent for a stent-cutting machine held by Spectralytics Inc. and awarded the latter company $22.35 million....To view the full article, register now.
Already a subscriber? Click here to view full article